Mymee

Mymee operates in the healthcare industry, offering a specialized solution for individuals with autoimmune diseases and long COVID. The company provides a custom mobile app, a proprietary data platform, and weekly analysis sessions with health coaches to help clients identify and manage symptom triggers. Mymee's services are designed to significantly improve health outcomes within an average of 17 weeks. The business primarily serves patients dealing with autoimmune conditions and long COVID, working closely with healthcare providers to tailor medication tapering based on genetics, personal preferences, and health needs. The company adheres to strict privacy standards, being HIPAA and SOC 2 compliant. Mymee's business model revolves around subscription-based services, generating revenue through ongoing client engagement and personalized health coaching. The market it operates in includes individuals with chronic health conditions seeking alternative and complementary health management solutions.

Keywords: autoimmune, long COVID, health coaching, mobile app, data platform, symptom triggers, personalized care, HIPAA compliant, SOC 2 compliant, medication tapering